10/26/12 Contest Update
Biotechs had another bad week. But how about those Giants!
At Friday’s close, the Contest median was up 28.56% YTD (vs. up 35.22% YTD a week ago). In comparison, the Nasdaq Biotech Index was up 29.84% YTD (vs. up 34.08% YTD a week ago), while the Nasdaq Composite Index was up 14.69% YTD (vs. up 15.37% YTD a week ago).
RKRW’s portfolio, up 113.75% YTD, gave up some more ground but continued in the lead by a wide margin. DONS’ portfolio, up 67.36% YTD and GENE’s portfolio, up 64.07% YTD, held on to second and third place.
At Friday's close, 3 of the 38 Contest portfolios were in the red, with just 16 of the 38 portfolios now beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week.
(Foreign stock prices are not converted to US$ in the weekly and YTD Top 5 & Bottom 5 tables, when posted.)
Portfolio adjustments: None.
Have a terrific weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
10/26/12
Rank Name Profit/Loss
1 RKRW 113,746
2 DONS 67,364
3 GENE 64,065
4 TNSAF 61,267
5 DOUGH 58,859
6 BULBA 53,139
7 ANON 52,833
8 BIOJIM 51,773
9 NP1986 50,575
10 LJM 50,040
Week's Top 5 Gainers
Symbol 10/19 10/26 Wk.%chg.
CHTP 1.35 1.86 37.78%
NPC.TO 0.40 0.47 18.99%
ZIOP 4.35 4.87 11.95%
KOOL 0.82 0.90 10.29%
UBI.AX 0.84 0.90 7.14%
Week's Worst 5 Losers
Symbol 10/19 10/26 Wk.%chg.
NGSX 0.36 0.25 -30.56%
IMGN 14.52 11.47 -21.01%
UTHR 54.86 45.25 -17.52%
XNPT 9.84 8.14 -17.28%
DSCO 2.85 2.42 -15.09% |
